陈玉卿接任复星医药产业发展公司董事长 复星医药及旗下公司接连变更法定代表人

金融界天眼查
May 23

天眼查App显示,近日,上海复星医药产业发展有限公司发生工商变更,吴以芳卸任法定代表人、董事长,由陈玉卿接任。不久前,陈玉卿刚接任复星医药(600196)法定代表人、董事长。

上海复星医药产业发展有限公司成立于2001年11月,注册资本39.5亿人民币,经营范围包括药品批发、药品委托生产、药物临床试验服务等,由上海复星医药(集团)股份有限公司全资持股。

责任编辑:栎树

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10